This brand name is authorized in Austria, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Poland, Romania, United Kingdom, United States
The drug POTELIGEO contains one active pharmaceutical ingredient (API):
|
1
Mogamulizumab
UNII YI437801BE - MOGAMULIZUMAB
|
|
Mogamulizumab is a defucosylated, humanised IgG1 kappa immunoglobulin that selectively binds to CCR4, a G protein-coupled receptor for CC chemokines that is involved in the trafficking of lymphocytes to various organs including the skin, resulting in depletion of the target cells. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| POTELIGEO Concentrate for solution for infusion | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| L01FX09 | Mogamulizumab | L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01F Monoclonal antibodies and antibody drug conjugates → L01FX Other monoclonal antibodies |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1783638 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 1181335001 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 533964 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 62292771 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 382328 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 9342 |
| Country: IT | Agenzia del Farmaco | Identifier(s): 047420017 |
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 4291422A1021 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1086750 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100416714 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W67184001 |
| Country: US | FDA, National Drug Code | Identifier(s): 42747-761 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
